Researchers aligned with the Nevada State Athletic Commission have found that use of a portable CT scanner can effectively screen professional boxers for intracranial hemorrhage following matches.
Researchers aligned with the Nevada State Athletic Commission have found that use of a portable CT scanner can effectively screen professional boxers for intracranial hemorrhage following matches.
Acute subdural hematoma is the most common injury in boxing and the leading cause of boxing fatalities. Early diagnosis of these intracranial injuries in boxers is associated with better outcomes, said Dr. Albert H. Capanna, a Nevada ringside physician and clinical professor of neurosurgery and pediatrics at the University of Nevada School of Medicine.
While the researchers found no clinical signs or symptoms of injury in any athletes, CT demonstrated in one boxer, who lost by a technical knockout, a 6.2-mm acute subdural hematoma with positive evidence of midline shift of 4.2 mm. Surgical evacuation is indicated in the management of acute subdural hematomas greater than 10 mm in thickness or associated with a midline shift of 5 mm.
The patient was promptly admitted to a nearby hospital, and the subdural hematoma improved over the subsequent two days, including complete resolution of the previous midline shift by discharge on the third day.
The Nevada state legislature has provided funding to the State Athletic Commission to have CT imaging available at athletic venues for immediate use in screening athletes with head injury. However, further studies are needed to risk stratify athletes before including them in long-term screening protocols because of the cumulative radiation dose associated with this practice, Capanna said.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.